Display options
Cite
Lavigne JP, Ranfaing J, Dunyach-Rémy C, et al. Synergistic Effect of Propolis and Antibiotics on Uropathogenic . Antibiotics (Basel). 2020;9(11)doi: 10.3390/antibiotics9110739.
Lavigne, J. P., Ranfaing, J., Dunyach-Rémy, C., & Sotto, A. (2020). Synergistic Effect of Propolis and Antibiotics on Uropathogenic . Antibiotics (Basel, Switzerland), 9(11), . https://doi.org/10.3390/antibiotics9110739
Lavigne, Jean-Philippe, et al. "Synergistic Effect of Propolis and Antibiotics on Uropathogenic ." Antibiotics (Basel, Switzerland) vol. 9,11 (2020). doi: https://doi.org/10.3390/antibiotics9110739
Lavigne JP, Ranfaing J, Dunyach-Rémy C, Sotto A. Synergistic Effect of Propolis and Antibiotics on Uropathogenic . Antibiotics (Basel). 2020 Oct 27;9(11). doi: 10.3390/antibiotics9110739. PMID: 33120958; PMCID: PMC7692270.
Copy Download .nbib Format: NLM
Share it on

Antibiotics (Basel). 2020 Oct 27;9(11). doi: 10.3390/antibiotics9110739.

Synergistic Effect of Propolis and Antibiotics on Uropathogenic .

Antibiotics (Basel, Switzerland)

Jean-Philippe Lavigne, Jérémy Ranfaing, Catherine Dunyach-Rémy, Albert Sotto

Affiliations

  1. Virulence Bactérienne et Maladies Infectieuses, INSERM U1047, Université de Montpellier, Service de Microbiologie et Hygiène Hospitalière, CHU Nîmes, 30029 Nîmes, France.
  2. Virulence Bactérienne et Maladies Infectieuses, INSERM U1047, Université de Montpellier, 30908 Nîmes, France.
  3. Virulence Bactérienne et Maladies Infectieuses, INSERM U1047, Université de Montpellier, Service des Maladies Infectieuses et Tropicales, CHU Nîmes, 30029 Nîmes, France.

PMID: 33120958 PMCID: PMC7692270 DOI: 10.3390/antibiotics9110739

Abstract

Urinary tract infections (UTIs) are the most common bacterial infections around the world. Uropathogenic

Keywords: Escherichia coli; MIC; antibiotics; bactericide curve; propolis; urinary tract infections

References

  1. Phytomedicine. 2013 Feb 15;20(3-4):262-9 - PubMed
  2. J Ethnopharmacol. 2011 Jan 27;133(2):253-60 - PubMed
  3. Front Microbiol. 2020 Jul 03;11:1509 - PubMed
  4. Cochrane Database Syst Rev. 2004;(3):CD001209 - PubMed
  5. Drugs. 2019 Sep;79(14):1529-1541 - PubMed
  6. Arch Intern Med. 2012 May 14;172(9):704-12 - PubMed
  7. Molecules. 2019 May 29;24(11): - PubMed
  8. Antimicrob Agents Chemother. 2020 Jul 22;64(8): - PubMed
  9. Clin Microbiol Rev. 2014 Jul;27(3):543-74 - PubMed
  10. Nat Rev Microbiol. 2015 May;13(5):269-84 - PubMed
  11. Front Cell Infect Microbiol. 2018 Oct 18;8:363 - PubMed
  12. PLoS One. 2018 Dec 4;13(12):e0207676 - PubMed
  13. Clin Microbiol Rev. 2015 Jul;28(3):565-91 - PubMed
  14. Infect Dis Clin North Am. 2014 Mar;28(1):1-13 - PubMed
  15. mBio. 2020 Apr 28;11(2): - PubMed
  16. Nat Prod Res. 2014;28(16):1293-6 - PubMed
  17. Curr Urol Rep. 2013 Oct;14(5):448-56 - PubMed
  18. Biotechnol Bioeng. 2006 Feb 5;93(2):297-305 - PubMed
  19. Clin Infect Dis. 2019 Dec 23;: - PubMed
  20. J Antimicrob Chemother. 2006 Apr;57(4):784-8 - PubMed
  21. Clin Infect Dis. 2012 Aug;55(4):534-42 - PubMed
  22. Urol Int. 2019;103(1):41-48 - PubMed
  23. Trends Mol Med. 2016 Nov;22(11):946-957 - PubMed
  24. BMC Infect Dis. 2015 Nov 25;15:545 - PubMed
  25. Phytother Res. 2016 Jun;30(6):894-905 - PubMed
  26. Int J Med Sci. 2014 Feb 07;11(4):327-36 - PubMed
  27. BMC Res Notes. 2011 Nov 29;4:522 - PubMed
  28. Cell Mol Biol (Noisy-le-grand). 2016 Dec 30;62(14):74-82 - PubMed
  29. Sci Rep. 2018 Jul 16;8(1):10706 - PubMed
  30. Clin Microbiol Infect. 1998 May;4(5):291 - PubMed
  31. Antimicrob Agents Chemother. 2013 Oct;57(10):4736-42 - PubMed
  32. PLoS One. 2018 Aug 23;13(8):e0202609 - PubMed
  33. Int J Med Sci. 2012;9(9):793-800 - PubMed
  34. Int J Antimicrob Agents. 2016 Apr;47(4):269-85 - PubMed
  35. Clin Infect Dis. 1996 Jan;22(1):91-9 - PubMed
  36. Antibiotics (Basel). 2020 Aug 24;9(9): - PubMed
  37. Lancet Infect Dis. 2010 Jan;10(1):43-50 - PubMed
  38. BMC Complement Altern Med. 2016 Nov 25;16(1):485 - PubMed

Publication Types